Exercise-induced hippocampal neurogenesis: 5-HT3 receptor antagonism by antipsychotics as a potential limiting factor in Schizophrenia

  • Subscribe to Molecular Psychiatry for full access:



Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.


  1. 1.

    Pajonk FG, Wobrock T, Gruber O, Scherk H, Berner D, Kaizl I, et al. Hippocampal plasticity in response to exercise in schizophrenia. Arch Gen Psychiatry. 2010;67:133–43.

  2. 2.

    Lappin JM, Morgan C, Chalavi S, Morgan KD, Reinders AA, Fearon P, et al. Bilateral hippocampal increase following first-episode psychosis is associated with good clinical, functional and cognitive outcomes. Psychol Med. 2014;44:1279–91.

  3. 3.

    Allen KM, Fung SJ, Weickert CS. Cell proliferation is reduced in the hippocampus in schizophrenia. Aust N Z J Psychiatry. 2016;50:473–80.

  4. 4.

    Malchow B, Keeser D, Keller K, Hasan A, Rauchmann BS, Kimura H, et al. Effects of endurance training on brain structures in chronic schizophrenia patients and healthy controls. Schizophr Res. 2016;173:182–91.

  5. 5.

    Scheewe TW, van Haren NE, Sarkisyan G, Schnack HG, Brouwer RM, de Glint M, et al. Exercise therapy, cardiorespiratory fitness and their effect on brain volumes: a randomised controlled trial in patients with schizophrenia and healthy controls. Eur Neuropsychopharmacol. 2013;23:675–85.

  6. 6.

    Rosenbaum S, Lagopoulos J, Curtis J, Taylor L, Watkins A, Barry BK, et al. Aerobic exercise intervention in young people with schizophrenia spectrum disorders; improved fitness with no change in hippocampal volume. Psychiatry Res. 2015;232:200–1.

  7. 7.

    Lin J, Chan SKW, Lee EHM, Chang WC, Tse M, Su WW, et al. Aerobic exercise and yoga improve neurocognitive function in women with early psychosis. NPJ Schizophr. 2015;1:15047.

  8. 8.

    Kondo M, Nakamura Y, Ishida Y, Shimada S. The 5-HT3 receptor is essential for exercise-induced hippocampal neurogenesis and antidepressant effects. Mol Psychiatry. 2015;20:1428–37.

  9. 9.

    Rammes G, Eisensamer B, Ferrari U, Shapa M, Gimpl G, Gilling K, et al. Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner. Mol Psychiatry. 2004;9:846–58.

  10. 10.

    Lummis SC, Thompson AJ, Bencherif M, Lester HA. Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor. J Pharmacol Exp Ther. 2011;339:125–31.

Download references

Author information


  1. Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Vancouver, BC, Canada

    • David D. Kim
    •  & Alasdair M. Barr
  2. Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada

    • William G. Honer
    •  & Ric M. Procyshyn


  1. Search for David D. Kim in:

  2. Search for Alasdair M. Barr in:

  3. Search for William G. Honer in:

  4. Search for Ric M. Procyshyn in:

Conflict of interest

AMB has received grants from Bristol-Myers Squibb and the Canadian Institutes of Health Research. WGH has received consulting fees from MDH Consulting, In Silico (no honorarium), Novartis, Eli Lilly, Roche, Otsuka, and Lundbeck; and received grants from the Canadian Institutes of Health Research. RMP has received consulting fees from Janssen, Lundbeck, and Otsuka; is on the speaker’s bureau for Janssen, Lundbeck, and Otsuka; and has received grants from the Canadian Institutes of Health Research. DDK declares that he has no conflict of interest.

Corresponding author

Correspondence to Ric M. Procyshyn.